A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming

Lihua Wang(Wenzhou Medical University), Tongke Chen(Wenzhou Medical University)
Journal of Translational Medicine
November 18, 2022
10.1186/s12967-022-03758-0
Cited by 10

Related Papers

Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer
|Journal of Experimental & Clinical Cancer Research|2019|194
MicroRNA-182 Suppresses HGF/SF-Induced Increases in Retinal Pigment Epithelial Cell Proliferation and Migration through Targeting c-Met
|PLoS ONE|2016|26
WZ35 Induces Metabolic Reprogramming of Hepatoma Cells Through ROS-Mediated Inhibition of YAP-GLUT1 Axis
|Research Square|2021|0